Preoperative risk stratification using plasma fibrinogen levels can predict lymphovascular invasion and poor prognosis in patients with upper urinary tract urothelial carcinoma

Kuroda,Kenji; Tasaki,Shinsuke; Asakuma,Junichi; Horiguchi,Akio; Ito,Keiichi

doi:10.3892/mco.2021.2264

Preoperative risk stratification using plasma fibrinogen levels can predict lymphovascular invasion and poor prognosis in patients with upper urinary tract urothelial carcinoma

Authors:
- Kenji Kuroda
- Shinsuke Tasaki
- Junichi Asakuma
- Akio Horiguchi
- Keiichi Ito
View Affiliations

Affiliations: Department of Urology, National Defense Medical College, Tokorozawa, Saitama 359‑8513, Japan
Published online on: March 13, 2021 https://doi.org/10.3892/mco.2021.2264
Article Number: 102
Copyright: © Kuroda et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

It has been previously indicated that preoperative plasma fibrinogen levels can correlate with cancer progression and be used as a useful predictor of lymph node metastasis or its premetastatic status such as lymphovascular invasion (LVI). In the present study, how preoperative plasma fibrinogen levels, considered in conjunction with other clinicopathological factors, can predict the presence of LVI and prognosisin patients with upper urinary tract urothelial carcinoma (UTUC) was examined. Medical records of 145 patients with UTUC who underwent radical nephroureterectomy (RNU) were retrospectively reviewed. The current study evaluated systemic inflammatory response markers including levels of plasma fibrinogen and other clinicopathological factors in orderto determine independent predictors of LVI and prognosis. The Cox proportional hazards model indicated that positive surgical margins and LVI were independent factors for poor cancer‑specific survival (CSS) rates and extraurothelial recurrence‑free survival (ERFS) rates. In addition, positive cytology, the presence of hydronephrosis and plasma fibrinogen levels were significant preoperative predictors of LVI. Furthermore, patients exhibiting two or more of higher fibrinogen levels (≥400 mg/dl), positive urine cytology and the presence of hydronephrosis were indicated to exhibit worse CSS or ERFS rates compared with patients exhibiting only one of the aforementioned factors or those with none of the three aforementioned factors in the multivariate analysis of the Cox proportional hazards model. In conclusion, hyperfibrinogenemia can be an independent predictor of the presence of LVI, and stratifying preoperative risk using fibrinogen levels, urine cytology and hydronephrosis can serve as the basis for selecting candidates for additional therapy before and/or after RNU in patients with UTUC.

View Figures

View References

1	Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Böhle A, Van Rhijn BW, Kaasinen E, et al: European association of urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol. 68:868–879. 2015.PubMed/NCBI View Article : Google Scholar
2	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2019. CA Cancer J Clin. 69:7–34. 2019.PubMed/NCBI View Article : Google Scholar
3	Liu JY, Dai YB, Zhou FJ, Long Z, Li YH, Xie D, Liu B, Tang J, Tan J, Yao K and He LY: Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: Oncological outcomes from a multicenter study. BMC Surg. 17(17)2017.PubMed/NCBI View Article : Google Scholar
4	Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T, Seruga B, Ocaña A, Tannock IF and Amir E: Prognostic role of platelet to lymphocyte ratio in solid tumors: A systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 23:1204–1212. 2014.PubMed/NCBI View Article : Google Scholar
5	Teng JJ, Zhang J, Zhang TY, Zhang S and Li BS: Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: A meta-analysis. Onco Targets Ther. 9:37–47. 2015.PubMed/NCBI View Article : Google Scholar
6	Koh CH, Bhoo-Pathy N, Ng KL, Jabir RS, Tan GH, See MH, Jamaris S and Taib NA: Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer. 113:150–158. 2015.PubMed/NCBI View Article : Google Scholar
7	Gunduz S, Mutlu H, Tural D, Yildiz O, Uysal M, Coskun HS and Bozcuk H: Platelet to lymphocyte ratio as a new prognostic for patients with metastatic renal cell cancer. Asia Pac J Clin Oncol. 11:288–292. 2015.PubMed/NCBI View Article : Google Scholar
8	Allin KH and Nordestgaard BG: Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 48:155–170. 2011.PubMed/NCBI View Article : Google Scholar
9	Kang M, Jeong CW, Kwak C, Kim HH and Ku JH: Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor. Oncotarget. 8:12891–12901. 2016.PubMed/NCBI View Article : Google Scholar
10	Yuksel OH, Akan S, Uukmez A, Yildirim C, Sahin A and Verit A: Preoperative Glasgow prognostic score as a predictor of primary bladder cancer recurrence. Mol Clin Oncol. 5:201–206. 2016.PubMed/NCBI View Article : Google Scholar
11	Yamashita H, Kitayama J, Kanno N, Yatomi Y and Nagawa H: Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BMC Cancer. 6(147)2006.PubMed/NCBI View Article : Google Scholar
12	Yamashita H, Kitayama J and Nagawa H: Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer. Jpn J Clin Oncol. 35:595–600. 2005.PubMed/NCBI View Article : Google Scholar
13	Palumbo JS, Potter JM, Kaplan LS, Talmage K, Jackson DG and Degen JL: Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res. 62:6966–6972. 2002.PubMed/NCBI
14	Fan S, Guan Y, Zhao G and An G: Association between plasma fibrinogen and survival in patients with small-cell lung carcinoma. Thorac Cancer. 9:146–151. 2018.PubMed/NCBI View Article : Google Scholar
15	Pichler M, Hutterer GC, Stojakovic T, Mannweiler S, Pummer K and Zigeuner R: High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients. Br J Cancer. 109:1123–1129. 2013.PubMed/NCBI View Article : Google Scholar
16	Erdem S, Amasyali AS, Aytac O, Onem K, Issever H and Sanli O: Increased preoperative levels of plasma fibrinogen and d dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics. Urol Oncol. 32:1031–1040. 2014.PubMed/NCBI View Article : Google Scholar
17	Sobin LH, Gospodarowicz MK and Wittekind Ch (eds): TNM Classification of Malignant Tumours, 7th Edition. Wiley-Blackwell, Hoboken, NJ, 2009.
18	The International Agency for Research on Cancer (IARC): Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs (IARC WHO Classification of Tumours) 1st Edition. Eble J, Epstein J, Sesterhenn I and Sauter G (eds). World Health Organization, Geneva, 2004.
19	Qu J, Qu X, Li Z, Zhang Jd, Liu J, Teng Ye, Jin B, Zhao Mf, Yu P, Shi J, et al: Prognostic model based on systemic inflammatory response and clinicopathological factors to predict outcome of patients with node-negative gastric cancer. PLoS One. 10(0128540)2015.PubMed/NCBI View Article : Google Scholar
20	Tanaka N, Kikuchi E, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakamura S and Oya M: Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma. BJU Int. 111:857–864. 2013.PubMed/NCBI View Article : Google Scholar
21	Kasuga J, Kawahara T, Takamoto D, Fukui S, Tokita T, Tadenuma T, Narahara M, Fusayasu S, Terao H, Izumi K, et al: Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer. BMC Cancer. 16(396)2016.PubMed/NCBI View Article : Google Scholar
22	Uemura K, Kawahara T, Yamashita D, Jikuya R, Abe K, Tatenuma T, Yokomizo Y, Izumi K, Teranishi JI, Makiyama K, et al: Neutrophil-to-lymphocyte ratio predicts prognosis in castration-resistant prostate cancer patients who received cabazitaxel chemotherapy. Biomed Res Int. 2017(7538647)2017.PubMed/NCBI View Article : Google Scholar
23	Lee JH, Ryu KW, Kim S and Bae JM: Preoperative plasma fibrinogen levels in gastric cancer patients correlate with extent of tumor. Hepatogastroenterology. 51:1860–1863. 2004.PubMed/NCBI
24	HKitayama JY, Hatano K, Tsuno N, Osada T, Watanabe T, Tsuruo T, Muto T and Nagawa H: Clustered cancer cells show a distinct adhesion behavior from single cell form under physiological shear conditions. J Exp Clin Cancer Res. 20:407–412. 2001.PubMed/NCBI
25	Çalışkan S and Sungur M: Fibrinogen and D-dimer levels in prostate cancer: Preliminary results. Prostate Int. 5:110–112. 2017.PubMed/NCBI View Article : Google Scholar
26	Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, Degen JL and Bugge TH: Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood. 96:3302–3309. 2000.PubMed/NCBI
27	Kuroda K, Asakuma J, Horiguchi A, Kawaguchi M, Shinchi M, Masunaga A, Tasaki S, Sato A and Ito K: Chronic kidney disease and positive surgical margins as prognosticators for upper urinary tract urothelial carcinoma patients undergoing radical nephroureterectomy. Mol Clin Oncol. 10:547–554. 2019.PubMed/NCBI View Article : Google Scholar
28	Bagoly Z: Cancer and thrombosis: A fresh look at an old story. Thromb Res. 136:1–2. 2015.PubMed/NCBI View Article : Google Scholar
29	Thurner EM, Krenn-Pilko S, Langsenlehner U, Stojakovic T, Pichler M, Gerger A, Kapp KS and Langsenlehner T: The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients. World J Urol. 33:1467–1473. 2015.PubMed/NCBI View Article : Google Scholar
30	Sakano S, Inamoto T, Inoue R, Matsumoto H, Nagao K, Yamamoto Y, Azuma H and Matsuyama H: Positive voided urine cytology predicts worse pathological findings of nephroureterectomy specimens in patients with upper tract urothelial carcinoma: Does selective ureteral cytology have an additional efficacy? Jpn J Clin Oncol. 45:968–972. 2015.PubMed/NCBI View Article : Google Scholar
31	Ito Y, Kikuchi E, Tanaka N, Miyajima A, Mikami S, Jinzaki M and Oya M: Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. J Urol. 185:1621–1626. 2011.PubMed/NCBI View Article : Google Scholar
32	Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Shirotake S, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, et al: The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: A multi-institutional study. Urol Oncol. 32:e19–e26. 2014.PubMed/NCBI View Article : Google Scholar
33	Kohada Y, Hayashi T, Goto K, Kobatake K, Abdi H, Honda Y, Sentani K, Inoue S, Teishima J, Awai K, et al: Preoperative risk classification using neutrophil-lymphocyte ratio and hydronephrosis for upper tract urothelial carcinoma. Jpn J Clin Oncol. 48:841–850. 2018.PubMed/NCBI View Article : Google Scholar
34	Chung PH, Krabbe LM, Darwish OM, Westerman ME, Bagrodia A, Gayed BA, Haddad AQ, Kapur P, Sagalowsky AI, Lotan Y and Margulis V: Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract. Urol Oncol Semin Orig Investig. 32:981–988. 2014.PubMed/NCBI View Article : Google Scholar